Invention Grant
- Patent Title: Antibodies specific to IL-17A and IL-17F
- Patent Title (中): IL-17A和IL-17F特异性抗体
-
Application No.: US12989373Application Date: 2009-04-22
-
Publication No.: US08679494B2Publication Date: 2014-03-25
- Inventor: Thomas Allen Ceska , Alistair James Henry
- Applicant: Thomas Allen Ceska , Alistair James Henry
- Applicant Address: BE Brussels
- Assignee: UCB Pharma S.A.
- Current Assignee: UCB Pharma S.A.
- Current Assignee Address: BE Brussels
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: GB0807413.0 20080423
- International Application: PCT/GB2009/001026 WO 20090422
- International Announcement: WO2009/130459 WO 20091029
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The present invention relates neutralising epitopes of IL-17A and IL-17F and antibodies which bind those epitopes. The present invention also relates to the therapeutic uses of the antibody molecules and methods for producing them.
Public/Granted literature
- US20110262443A1 Epitopes Of Il-17a And Il-17f And Antibodies Specific Thereto Public/Granted day:2011-10-27
Information query
